Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax’s CpG 1018 Adjuvant for Biological E’s COVID-19 Vaccine Candidate

EMERYVILLE, Calif. and HYDERABAD, India: EMERYVILLE, Calif. and HYDERABAD, India, July 6, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Dynavax, Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines and Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company, today announced the execution of a commercial supply...

Click to view original post